Raj S. Pruthi, MD, MHA, FACS

Raj S. Pruthi, MD, MHA, FACS

Chief Medical OfficeratenGene Therapeutics· In the 2024 proxy

Pay in FY2024

Raj S. Pruthi, MD, MHA, FACS was paid $2.5M in FY2024 (Oct).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each enGene Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. enGene TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?